- Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetesNeale D Cohen
Baker IDI Heart and Diabetes Institute, Melbourne, Australia
Diabetes Technol Ther 15:544-9. 2013..The long-term effects of CSII in patients with type 1 diabetes in comparison with those educated for iMDI are poorly documented...
- The rationale for combining GLP-1 receptor agonists with basal insulinNeale D Cohen
Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
Med J Aust 199:246-9. 2013....